留言板

尊敬的读者、作者、审稿人, 关于本刊的投稿、审稿、编辑和出版的任何问题, 您可以本页添加留言。我们将尽快给您答复。谢谢您的支持!

姓名
邮箱
手机号码
标题
留言内容
验证码

超声引导下移植肝穿刺活检术后出血的危险因素分析

郭光辉 许尔蛟 郑荣琴 曾庆劲 李凯

郭光辉, 许尔蛟, 郑荣琴, 等. 超声引导下移植肝穿刺活检术后出血的危险因素分析[J]. 器官移植, 2015, 6(6): 397-400. doi: 10.3969/j.issn.1674-7445.2015.06.010
引用本文: 郭光辉, 许尔蛟, 郑荣琴, 等. 超声引导下移植肝穿刺活检术后出血的危险因素分析[J]. 器官移植, 2015, 6(6): 397-400. doi: 10.3969/j.issn.1674-7445.2015.06.010
Guo Guanghui, Xu Erjiao, Zheng Rongqin, et al. Analysis of risk factors of hemorrhage after ultrasound-guided liver graft biopsy[J]. ORGAN TRANSPLANTATION, 2015, 6(6): 397-400. doi: 10.3969/j.issn.1674-7445.2015.06.010
Citation: Guo Guanghui, Xu Erjiao, Zheng Rongqin, et al. Analysis of risk factors of hemorrhage after ultrasound-guided liver graft biopsy[J]. ORGAN TRANSPLANTATION, 2015, 6(6): 397-400. doi: 10.3969/j.issn.1674-7445.2015.06.010

超声引导下移植肝穿刺活检术后出血的危险因素分析

doi: 10.3969/j.issn.1674-7445.2015.06.010
基金项目: 

国家自然科学基金青年科学基金项目 81301931

详细信息
    通讯作者:

    李凯, Email:bobyman@163.com

  • 中图分类号: R617;R364.1+3

Analysis of risk factors of hemorrhage after ultrasound-guided liver graft biopsy

More Information
  • 摘要:   目的  探讨超声引导下移植肝穿刺活组织检查(活检)出血的危险因素。  方法  回顾性分析2013年2月至2015年4月在中山大学附属第三医院行超声引导下肝穿刺活检的51例肝移植患者的临床资料。以穿刺术后出血作为应变量, 将患者年龄、性别、凝血功能、活检时间、活检次数、活检组织条数、是否使用抗凝药物及患者能否配合呼吸屏气作为自变量, 对所有自变量进行多因素非条件Logistic回归分析, 筛选出与超声引导下移植肝穿刺活检出血相关的危险因素。  结果  51例肝移植患者共穿刺活检84次, 术后出血5例(6%)。多因素非条件Logistic回归分析显示有明显出血倾向、使用抗凝药物及呼吸配合欠佳是肝穿刺活检出血的独立危险因素(OR分别为8.71、3.16、2.03, 均为P < 0.05)。  结论  有明显出血倾向、使用抗凝药物及呼吸配合欠佳是超声引导下移植肝穿刺活检出血的危险因素。

     

  • 表  1  超声引导下移植肝穿刺活检出血的多因素非条件Logistic回归分析结果

    Table  1.   Logistic regression analysis result of hemorrhage after ultrasound-guided liver graft biopsy

    变量 β SE Wald χ2 P OR
    明显出血倾向 2.331 0.761 9.536 0.002 8.71
    使用抗凝药物 0.991 0.394 11.723 0.003 3.16
    呼吸配合欠佳 0.712 0.494 6.719 0.031 2.03
    下载: 导出CSV
  • [1] Banff Working Group on Liver Allograft Pathology. Importance of liver biopsy findings in immunosuppression management: biopsy monitoring and working criteria for patients with operational tolerance[J]. Liver Transpl, 2012, 18(10):1154-1170. doi: 10.1002/lt.v18.10
    [2] Lenci I, Tisone G, Di Paolo D, et al. Safety of complete and sustained prophylaxis withdrawal in patients liver-transplanted for HBV-related cirrhosis at low risk of HBV recurrence[J]. J Hepatol, 2011, 55(3):587-593. doi: 10.1016/j.jhep.2010.12.036
    [3] Seeff LB, Everson GT, Morgan TR, et al. Complication rate of percutaneous liver biopsies among persons with advanced chronic liver disease in the HALT-C trial[J]. Clin Gastroenterol Hepatol, 2010, 8(10):877-883. doi: 10.1016/j.cgh.2010.03.025
    [4] Caldwell S, Northup PG. Bleeding complication with liver biopsy: is it predictable?[J]. Clin Gastroenterol Hepatol, 2010, 8(10):826-829. doi: 10.1016/j.cgh.2010.06.010
    [5] Boursier J, Brochard C, Bertrais S, et al. Combination of blood tests for significant fibrosis and cirrhosis improves the assessment of liver-prognosis in chronic hepatitis C[J]. Aliment Pharmacol Ther, 2014, 40(2):178-188. doi: 10.1111/apt.2014.40.issue-2
    [6] Liou IW. Management of end-stage liver disease[J]. Med Clin North Am, 2014, 98(1):119-152. doi: 10.1016/j.mcna.2013.09.006
    [7] Guerrero-Misas M, Rodríguez-Perálvarez M, De la Mata M. Strategies to improve outcome of patients with hepatocellular carcinoma receiving a liver transplantation[J]. World J Hepatol, 2015, 7(4):649-661. doi: 10.4254/wjh.v7.i4.649
    [8] Tariq H, Nasir H. Spectrum of histopathological findings in live donor liver graft biopsies[J]. J Coll Physicians Surg Pak, 2015, 25(6):412-416. http://cn.bing.com/academic/profile?id=2411241264&encoded=0&v=paper_preview&mkt=zh-cn
    [9] Hu WY, Wu LQ, Su Z, et al. Expression of human leukocyte antigen-G and acute rejection in patients following liver transplantation[J]. Exp Ther Med, 2014, 8(4):1291-1295. http://cn.bing.com/academic/profile?id=2058206652&encoded=0&v=paper_preview&mkt=zh-cn
    [10] 董辉, 夏春燕, 王斌, 等.肝移植术后1 052例次肝活组织检查病理学诊断分析[J].中华肝脏病杂志, 2010, 18(4):300-301.

    Dong H, Xia CY, Wang B, et al. Pathological diagnosis of 1 052 liver biopsies after liver transplantation[J]. Chin J Hepatol, 2010, 18(4):300-301.
    [11] Howlett DC, Drinkwater KJ, Lawrence D, et al. Findings of the UK national audit evaluating image-guided or image-assisted liver biopsy.part Ⅱ. minor and major complications and procedure-related mortality[J]. Radiology, 2013, 266(1):226-235. doi: 10.1148/radiol.12120224
    [12] Sparchez Z. Complications after percutaneous liver biopsy in diffuse hepatopathies[J]. Rom J Gastroenterol, 2005, 14(4):379-384. http://cn.bing.com/academic/profile?id=2417957403&encoded=0&v=paper_preview&mkt=zh-cn
    [13] Filingeri V, Sforza D, Tisone G. Complications and risk factors of a large series of percutaneous liver biopsies in patients with liver transplantation or liver disease[J]. Eur Rev Med Pharmacol Sci, 2015, 19(9):1621-1629. http://cn.bing.com/academic/profile?id=2163975904&encoded=0&v=paper_preview&mkt=zh-cn
    [14] 张瑶, 王丽萍, 罗艳, 等.超声引导下肝脏穿刺活检并发症探讨与研究[J].中国医药导报, 2013, 10(2):94-96. http://www.cnki.com.cn/Article/CJFDTOTAL-YYCY201302039.htm

    Zhang Y, Wang LP, Luo Y, et al. Discussion and research on complications of liver biopsy under the guidance of color Doppler ultrasound[J]. Chin Med Herald, 2013, 10(2):94-96. http://www.cnki.com.cn/Article/CJFDTOTAL-YYCY201302039.htm
    [15] 余松远, 邓远, 屈亚莉, 等.超声引导肝穿刺活检并发症及处理对策.中华超声影像学杂志, 2011, 20(6):496-498. http://d.wanfangdata.com.cn/periodical_zhcsyx201106011.aspx

    Yu SY, Deng Y, Qu YL, et al. Analysis and management of the complications of ultrasound-guided hepatic puncture biopsy[J]. Chin J Ultrason, 2011, 20(6):496-498. http://d.wanfangdata.com.cn/periodical_zhcsyx201106011.aspx
    [16] Mueller M, Kratzer W, Oeztuerk S, et al. Percutaneous ultrasonographically guided liver punctures: an analysis of 1 961 patients over a period of ten years[J]. BMC Gastroenterol, 2012, 12:173. doi: 10.1186/1471-230X-12-173
    [17] Warkentin AE, Donadini MP, Spencer FA, et al. Bleeding risk in randomized controlled trials comparing warfarin and aspirin: a systematic review and meta-analysis[J]. J Thromb Haemost, 2012, 10(4):512-520. doi: 10.1111/j.1538-7836.2012.04635.x
    [18] Aribaȿ BK, Arda K, Ciledagğ N, et al. Accuracy and safety of percutaneous US-guided needle biopsies in specific focal liver lesions: comparison of large and small needles in 1 300 patients[J]. Panminerva Med, 2012, 54(3):233-239. http://cn.bing.com/academic/profile?id=2192939528&encoded=0&v=paper_preview&mkt=zh-cn
  • 加载中
表(1)
计量
  • 文章访问数:  132
  • HTML全文浏览量:  119
  • PDF下载量:  4
  • 被引次数: 0
出版历程
  • 收稿日期:  2015-08-10
  • 网络出版日期:  2021-01-19
  • 刊出日期:  2015-11-15

目录

    /

    返回文章
    返回